Cargando…
An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale
Combination therapies, where two drugs acting through different mechanisms are administered simultaneously, are one of the most efficient approaches currently used to treat malaria infections. However, the different pharmacokinetic profiles often exhibited by the combined drugs tend to decrease trea...
Autores principales: | Biosca, Arnau, Dirscherl, Lorin, Moles, Ernest, Imperial, Santiago, Fernàndez-Busquets, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680488/ https://www.ncbi.nlm.nih.gov/pubmed/31315185 http://dx.doi.org/10.3390/pharmaceutics11070341 |
Ejemplares similares
-
Coupling the Antimalarial Cell Penetrating Peptide TP10 to Classical Antimalarial Drugs Primaquine and Chloroquine Produces Strongly Hemolytic Conjugates
por: Aguiar, Luísa, et al.
Publicado: (2019) -
Characterization of Domiphen Bromide as a New Fast-Acting Antiplasmodial Agent Inhibiting the Apicoplastidic Methyl Erythritol Phosphate Pathway
por: Biosca, Arnau, et al.
Publicado: (2022) -
Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit(®)-Containing Liposomes
por: Martí Coma-Cros, Elisabet, et al.
Publicado: (2018) -
The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures
por: Bouzón-Arnáiz, Inés, et al.
Publicado: (2022) -
Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs
por: Martí Coma-Cros, Elisabet, et al.
Publicado: (2018)